Law Offices of Howard G. Smith announces an investigation on behalf of Cibus, Inc. (“Cibus” or the “Company”) (NASDAQ: CBUS) investors concerning the Company’s possible violations of federal securities laws.

On June 4, 2024, Bonitas Research published a report alleging, among other things, that there is “no evidence that Cibus’ gene-editing technology brings desirable new crops to market,” and, instead, there are “farmer complaints of lower crop yields and lost revenues, along with multiple examples of large seed manufacturers and distributors walking away from joint ventures and partnerships with Cibus for a variety of seed types and seed traits.”

On this news, Cibus’ stock price fell as much as 13% during intraday trading on June 4, 2024, thereby injuring investors.

If you purchased Cibus securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847 or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240604792940/en/